Literature DB >> 31740726

Neuromodulation of the prefrontal cortex facilitates diet-induced weight loss in midlife women: a randomized, proof-of-concept clinical trial.

Carlos Amo Usanos1, Pedro L Valenzuela2, Pedro de la Villa2,3, Santiago Milla Navarro2, Andresa Evelem de Melo Aroeira2, Ignacio Amo Usanos1, Liliana Martínez Cancio4, Luis Cuesta Villa1, Hetal Shah5, Greta Magerowski6, Miguel Alonso-Alonso7.   

Abstract

BACKGROUND: High body mass index (BMI) is associated with neurocognitive impairments that contribute to overeating and interfere with weight loss efforts. Overweight and obesity at midlife can accelerate neurodegenerative changes and increase the risk of late-life dementia. Noninvasive neuromodulation represents a novel, affordable and scalable approach to improve neurocognitive function in this context. The purpose of this proof-of-concept study was to examine whether transcranial direct current stimulation (tDCS) aimed at enhancing prefrontal cortex activity could enhance weight loss, in combination with a hypocaloric diet, and study underlying mechanisms.
METHODS: Overall, 38 women with BMI 25-35 kg/m2 underwent a 4 week randomized, double-blinded, sham-controlled, and parallel-design intervention, during which they received eight sessions of tDCS (n = 18 sham, n = 20 active) in combination with a diet (caloric goal of 20 kcal/kg/day). We evaluated longitudinal changes in body weight, appetite and food craving. In addition, we examined the contribution of cognitive-executive processes via food-modified computerized tasks.
RESULTS: We found that the active group had more reduction in body weight than the sham group throughout the study (p = 0.020) and significant weekly weight loss. At 4 weeks, the active group lost 2.32% of initial body weight (sham: 1.29%). Components of subjective appetite and food craving showed a trend toward more reduction in the active group. These changes were paralleled by significant improvements in task performance in the active group, particularly in a dual task that required inhibitory control and working memory (p = 0.007-0.031). Improvement in inhibitory control performance predicted reduction in lack of control overeating, explaining 43.5% of its variance at the end of the study (p = 0.003). No significant adverse effects were observed.
CONCLUSIONS: Our results provide proof-of-concept validation of prefrontal-targeted tDCS, combined with a diet, in midlife women with excess body weight, paving the way for larger studies evaluating clinical efficacy and long-term effects of this intervention.

Entities:  

Mesh:

Year:  2019        PMID: 31740726     DOI: 10.1038/s41366-019-0486-x

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  39 in total

Review 1.  Long-term weight loss maintenance.

Authors:  Rena R Wing; Suzanne Phelan
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

Review 2.  An Evolutionary Perspective on Why Food Overconsumption Impairs Cognition.

Authors:  Mark P Mattson
Journal:  Trends Cogn Sci       Date:  2019-01-19       Impact factor: 20.229

Review 3.  2003-2013: a decade of body mass index, Alzheimer's disease, and dementia.

Authors:  Tim L Emmerzaal; Amanda J Kiliaan; Deborah R Gustafson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Cognitive and neuromodulation strategies for unhealthy eating and obesity: Systematic review and discussion of neurocognitive mechanisms.

Authors:  Laura Forcano; Fernanda Mata; Rafael de la Torre; Antonio Verdejo-Garcia
Journal:  Neurosci Biobehav Rev       Date:  2018-02-09       Impact factor: 8.989

5.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

Review 6.  Medical hazards of obesity.

Authors:  F X Pi-Sunyer
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

7.  Midlife overweight and obesity increase late-life dementia risk: a population-based twin study.

Authors:  W L Xu; A R Atti; M Gatz; N L Pedersen; B Johansson; L Fratiglioni
Journal:  Neurology       Date:  2011-05-03       Impact factor: 9.910

Review 8.  Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.

Authors:  D Val-Laillet; E Aarts; B Weber; M Ferrari; V Quaresima; L E Stoeckel; M Alonso-Alonso; M Audette; C H Malbert; E Stice
Journal:  Neuroimage Clin       Date:  2015-03-24       Impact factor: 4.881

9.  A comprehensive examination of health conditions associated with obesity in older adults.

Authors:  Ruth E Patterson; Laura L Frank; Alan R Kristal; Emily White
Journal:  Am J Prev Med       Date:  2004-12       Impact factor: 5.043

10.  Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.

Authors:  Miriam E Bocarsly; Maria Fasolino; Gary A Kane; Elizabeth A LaMarca; Gregory W Kirschen; Ilia N Karatsoreos; Bruce S McEwen; Elizabeth Gould
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

View more
  3 in total

1.  Noninvasive neuromodulation of the prefrontal cortex in young women with obesity: a randomized clinical trial.

Authors:  Vivian Marques Miguel Suen; Miguel Alonso-Alonso; Priscila Giacomo Fassini; Sai Krupa Das; Greta Magerowski; Júlio Sérgio Marchini; Wilson Araújo da Silva Junior; Isabela Rozatte da Silva; Rafaella de Souza Ribeiro Salgueiro; Cássia Dias Machado
Journal:  Int J Obes (Lond)       Date:  2020-02-19       Impact factor: 5.095

Review 2.  Electroceuticals in the Gastrointestinal Tract.

Authors:  Khalil B Ramadi; Shriya S Srinivasan; Giovanni Traverso
Journal:  Trends Pharmacol Sci       Date:  2020-10-27       Impact factor: 14.819

Review 3.  Neurobiological regulation of eating behavior: Evidence based on non-invasive brain stimulation.

Authors:  Theresa Ester; Stephanie Kullmann
Journal:  Rev Endocr Metab Disord       Date:  2021-12-04       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.